Compounds > xanthenes
Page last updated: 2024-08-18

xanthenes and Carcinoma, Non-Small Cell Lung

xanthenes has been researched along with Carcinoma, Non-Small Cell Lung in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Liu, C; Niu, H; Shen, D; Wang, Y1
Fu, W; Lao, Y; Li, X; Meng, X; Qian, J; Tan, H; Tu, S; Xu, H; Xu, L; Xu, N; Zhang, L; Zhou, Q1
Jank, BJ; Lanuti, M; Mathisen, DJ; Ott, HC; Ren, X; Tapias, LF1
Barcellos-Hoff, MH; Bolourchi, S; Bouquet, S; Du, S; Lo, CH; Parry, R; Pellicciotta, I1
Casibang, M; Moody, TW1

Other Studies

5 other study(ies) available for xanthenes and Carcinoma, Non-Small Cell Lung

ArticleYear
Gambogenic acid exerts anticancer effects in cisplatin‑resistant non‑small cell lung cancer cells.
    Molecular medicine reports, 2020, Volume: 21, Issue:3

    Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Resistance, Neoplasm; G1 Phase; Humans; Lung Neoplasms; Neoplasm Proteins; Xanthenes

2020
Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth.
    Cell death & disease, 2018, 02-15, Volume: 9, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Protein Kinase Inhibitors; Receptors, Fibroblast Growth Factor; Signal Transduction; Tumor Burden; Xanthenes; Xenograft Model Antitumor Assays

2018
Ex vivo non-invasive assessment of cell viability and proliferation in bio-engineered whole organ constructs.
    Biomaterials, 2015, Volume: 52

    Topics: Animals; Bioengineering; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Endothelial Progenitor Cells; Human Umbilical Vein Endothelial Cells; Humans; Indicators and Reagents; Lung; Lung Neoplasms; Male; Organ Culture Techniques; Oxazines; Perfusion; Rats, Sprague-Dawley; Regeneration; Tissue Engineering; Tissue Scaffolds; Xanthenes

2015
Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
    International journal of radiation oncology, biology, physics, 2015, Jan-01, Volume: 91, Issue:1

    Topics: Amino Acids; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chemotherapy, Adjuvant; Comet Assay; DNA Damage; Histones; Humans; In Vitro Techniques; Lung Neoplasms; Mice; Phosphorylation; Protein Serine-Threonine Kinases; Radiation Tolerance; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta; Tumor Suppressor Protein p53; Xanthenes

2015
AH6809 antagonizes non-small cell lung cancer prostaglandin receptors.
    Lung cancer (Amsterdam, Netherlands), 2002, Volume: 36, Issue:1

    Topics: Binding Sites; Calcium; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Membrane; Colony-Forming Units Assay; Cyclic AMP; Cytoplasm; Dinoprostone; DNA Primers; Humans; Lung Neoplasms; Prostaglandin Antagonists; Receptors, Prostaglandin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Xanthenes; Xanthones

2002